-
What Maxim Thinks Of Cytori After Its Huge Week
Wednesday, April 8, 2015 - 12:53pm | 188In a report published Wednesday, Maxim Group analyst Jason Kolbert discussed Cytori Therapeutics Inc (NASDAQ: CYTX)'s announcement earlier this week that the European Medicines Agency Committee for Orphan Medicinal Products has designed Cytori's ECC S-50 cellular therapeutic as an orphan...